Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,680 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

Tumor-specific T Cells in Lung Cancer

NCT02515760

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Division of Thoracic Surgery, Technical University of Munich, Munich, Germany Munich, Germany
View Trial Details
Active, Not Recruiting

Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

NCT03425643

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0028) Gilbert, Arizona, United States
  • Western Regional Medical Center, Inc. ( Site 0050) Goodyear, Arizona, United States
  • University of Arizona Cancer Center - Dignity Health ( Site 0062) Phoenix, Arizona, United States
  • University of Arizona Cancer Center ( Site 0012) Tucson, Arizona, United States
View all 227 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

NCT04956692

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • St. Bernards Medical Center ( Site 0103) Jonesboro, Arkansas, United States
  • St Joseph Heritage Healthcare-Oncology ( Site 0102) Fullerton, California, United States
  • Cancer Blood and Specialty Clinic ( Site 0105) Los Alamitos, California, United States
  • PIH Health Hematology Medical Oncology ( Site 0106) Whittier, California, United States
View all 126 locations
View Trial Details
Active, Not Recruiting

A Study of NDI 1150-101 in Patients With Solid Tumors

NCT05128487

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +36 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK Positive NSCLC Patients

NCT04127110

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Institut Jules Bordet-Hopital Universitaire ULB Brussels, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Universitair Ziekenhuis Antwerpen Edegem, Belgium
  • CHU-UCL Namur - CHU Mont Godinne - UCL Namur Yvoir, Belgium
View all 26 locations
View Trial Details

Related conditions